Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kyounghwan Roh"'
Autor:
Sang Eun Lee, Seung-Ju Lee, Song-Ee Kim, Kinam Kim, Boyoung Cho, Kyounghwan Roh, Soo-Chan Kim
Publikováno v:
JCI Insight, Vol 6, Iss 2 (2021)
BACKGROUND Recessive dystrophic epidermolysis bullosa (RDEB) is an incurable disease that causes severe mucocutaneous fragility due to mutations in COL7A1 (encoding type VII collagen [C7]). In this phase I/IIa trial, we evaluated the safety and possi
Externí odkaz:
https://doaj.org/article/f7e7620dd88147ef9078270d68862cd6
Autor:
Eun Hye Park, Hee‐suk Lim, Seunghee Lee, Kyounghwan Roh, Kwang‐Won Seo, Kyung‐Sun Kang, Kichul Shin
Publikováno v:
Stem Cells Translational Medicine, Vol 7, Iss 9, Pp 636-642 (2018)
Abstract Based on immunomodulatory actions of human umbilical cord blood‐derived mesenchymal stem cells (hUCB‐MSCs), in vitro or preclinical studies of hUCB‐MSCs have been conducted extensively in rheumatoid arthritis (RA). However, few human t
Externí odkaz:
https://doaj.org/article/ae6004341b014da292ed0e69eee045d3
Autor:
MinSoo Kim, Dasom Gong, Myounghee Han, Kyounghwan Roh, Hojun Koo, Seounghee Lee, Kyung-Sun Kang
Mesenchymal stem cells (MSCs) are a promising tool for treating immune disorders. However, the effect and mechanism of canine MSCs compared with other commercialized biologics for treating immune disorders have not been well studied. In this study, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::04f0c58d7c12927488ed352c5cb8f7c6
https://doi.org/10.21203/rs.3.rs-2656900/v1
https://doi.org/10.21203/rs.3.rs-2656900/v1
Autor:
Song-Ee Kim, Sang Eun Lee, Soo Chan Kim, Boyoung Cho, Kinam Kim, Kyounghwan Roh, Seung-Ju Lee
Publikováno v:
JCI Insight
JCI Insight, Vol 6, Iss 2 (2021)
JCI Insight, Vol 6, Iss 2 (2021)
BACKGROUND Recessive dystrophic epidermolysis bullosa (RDEB) is an incurable disease that causes severe mucocutaneous fragility due to mutations in COL7A1 (encoding type VII collagen [C7]). In this phase I/IIa trial, we evaluated the safety and possi